Agilent Technologies (A) PEG Ratio: History & Chart

Agilent Technologies, Inc.(A)

Medical - Diagnostics & Research · Santa Clara, CA

$144.51-2.34 (-1.59%)

Delayed quote: Sep 9, 2026, 10:35 AM EDT

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

18,000 employees

www.agilent.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Padraig McDonnell

View full financials

A PEG Ratio Metrics

PEG RATIO

9.44

PEG RATIO AVG TTM

7.54

PEG RATIO AVG 3Y

13.88

PEG RATIO AVG 5Y

11.22

PEG RATIO AVG 10Y

7.31

PEG RATIO AVG 15Y

5.93

PEG RATIO AVG 20Y

2.28

CURRENT VS TTM AVG

+25.28%

CURRENT VS 3Y AVG

-32.01%

CURRENT VS 5Y AVG

-15.86%

CURRENT VS 10Y AVG

+29.07%

CURRENT VS 15Y AVG

+59.24%

CURRENT VS 20Y AVG

+313.13%

SECTOR MEDIAN · HEALTHCARE

1.81

median of 59 covered companies

CURRENT VS SECTOR MEDIAN

+421.55%

vs the sector median at left

NAME	MARKET CAP	PEG RATIO	TTM	3Y	5Y
Agilent Technologies, Inc. (A)	$40.81B	9.44	7.54	13.88	11.22
IDEXX Laboratories, Inc. (IDXX)vs ›	$40.93B	2.31	4.41	3.66	3.13
IQVIA Holdings Inc. (IQV)vs ›	$42.17B	6.34	8.50	5.12	3.87
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$42.75B	N/A	0.14	0.14	0.14
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$33.94B	N/A	1.85	3.49	3.16
Humana Inc. (HUM)vs ›	$47.90B	N/A	0.45	0.32	0.59
Alcon Inc. (ALC)vs ›	$33.52B	N/A	5.21	5.21	4.55
Becton, Dickinson and Company (BDX)vs ›	$49.60B	3.32	1.76	0.97	0.68
Edwards Lifesciences Corporation (EW)vs ›	$49.88B	7.25	0.05	5.11	4.08
ResMed Inc. (RMD)vs ›	$31.77B	2.00	1.36	1.79	1.56

NAME

MARKET CAP

PEG RATIO

TTM

Agilent Technologies, Inc. (A)

$40.81B

9.44

7.54

13.88

11.22

IDEXX Laboratories, Inc. (IDXX)vs ›

$40.93B

2.31

4.41

3.66

3.13

IQVIA Holdings Inc. (IQV)vs ›

$42.17B

6.34

8.50

5.12

3.87

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$42.75B

N/A

0.14

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$33.94B

N/A

1.85

3.49

3.16

Humana Inc. (HUM)vs ›

$47.90B

N/A

0.45

0.32

0.59

Alcon Inc. (ALC)vs ›

$33.52B

N/A

5.21

4.55

Becton, Dickinson and Company (BDX)vs ›

$49.60B

3.32

1.76

0.97

0.68

Edwards Lifesciences Corporation (EW)vs ›

$49.88B

7.25

0.05

5.11

4.08

ResMed Inc. (RMD)vs ›

$31.77B

2.00

1.36

1.79

1.56

PEG Ratio FAQ

What is the PEG ratio for Agilent Technologies, Inc. (A)?

The PEG ratio for A stock is 9.44.

Is Agilent Technologies, Inc.'s PEG ratio high or low?

The PEG ratio of 9.44 is 16% below its 4-year average of 11.22, near the low end of its 4-year range (0.56–34.21).

What is the TTM average PEG ratio for Agilent Technologies, Inc. (A)?

The TTM average PEG ratio for A stock is 7.54.

What is the 3Y average PEG ratio for Agilent Technologies, Inc. (A)?

The 3Y average PEG ratio for A stock is 13.88.

What is the 5Y average PEG ratio for Agilent Technologies, Inc. (A)?

The 5Y average PEG ratio for A stock is 11.22.

What is the 10Y average PEG ratio for Agilent Technologies, Inc. (A)?

The 10Y average PEG ratio for A stock is 7.31.

What is the 15Y average PEG ratio for Agilent Technologies, Inc. (A)?

The 15Y average PEG ratio for A stock is 5.93.

What is the 20Y average PEG ratio for Agilent Technologies, Inc. (A)?

The 20Y average PEG ratio for A stock is 2.28.

DATE	PEG RATIO
2025-10-31	9.44
2024-10-31	5.63
2023-10-31	34.21
2022-10-31	6.26
2021-10-31	0.56
2019-10-31	0.09
2017-10-31	0.65
2016-10-31	1.67
2012-10-31	0.58
2011-10-31	0.19
2009-10-31	1.89
2008-10-31	0.46
2006-10-31	0.00
2002-10-31	0.01
2000-10-31	0.76
1999-10-31	0.16

DATE

PEG RATIO

2025-10-31

9.44

2024-10-31

5.63

2023-10-31

34.21

2022-10-31

6.26

2021-10-31

0.56

2019-10-31

0.09

2017-10-31

0.65

2016-10-31

1.67

2012-10-31

0.58

2011-10-31

0.19

2009-10-31

1.89

2008-10-31

0.46

2006-10-31

0.00

2002-10-31

0.01

2000-10-31

0.76

1999-10-31

0.16

PEG Ratio: 9.44

A PEG Ratio Chart

A Average PEG Ratio Chart

A Current vs Average PEG Ratio Chart

A PEG Ratio Metrics

A Competitors' PEG Ratio

Growth-Adjusted Valuation

PEG Ratio Formula & Definition

PEG Ratio FAQ

A PEG Ratio History

Related Metrics